Global Antibody Hit Generation and Screening Market Analysis and Forecast 2023-2032, by Application, Technologies, Antibody Type, Region and Key Player Profiles

News provided by

Jan 09, 2024, 18:30 ET

DUBLIN, Jan. 9, 2024 /PRNewswire/ -- The "Global Antibody Hit Generation and Screening Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.

The Global Antibody Hit Generation and Screening Market report offers a detailed and comprehensive analysis of the industry, providing valuable insights into market trends, growth drivers, challenges, and future opportunities. The report covers key segments, competitive landscape, and emerging technologies, offering stakeholders a holistic view of the global market.

The study identifies and analyzes the primary drivers influencing market growth. Factors such as the increasing prevalence of chronic diseases, advancements in antibody engineering, and rising investments in research and development are explored. Additionally, the growing demand for personalized medicine and the expanding biopharmaceutical industry contribute to the positive trajectory of the market.

Key Questions Answered in the Report:

What are the major market drivers, challenges and opportunities in the global antibody hit generation and screening market?
How the antibody hit generation and screening market evolves and what did is its scope in the future?
How will each segment of the global antibody hit generation and screening market grow during the forecast period?
How will the industry evolve during the forecast period?
What are the key developmental strategies implemented by the key players to stand out in this market?

Market Segmentation:

Segmentation by Application

Cancer
Autoimmune diseases
Infectious diseases

Segmentation by Technologies

Hit Generation
Phage display
Yeast display
Ribosome display
B-cell hybridoma technology
Computational tools
Screening

Segmentation by Antibody Type

Humanized Antibody
Human Antibody
Chimeric Antibody
Murine Antibody

Segmentation by Region

North America
Europe
Asia-Pacific
Latin America
Rest-of-the-World

Some prominent players established in this market are:

Creative Biolabs
F. Hoffmann-La Roche Ltd.
WuXi AppTec
ICOS Therapeutics

Key Topics Covered:

1. Market
1.1 Global Market Outlook
1.2 Product Definition
1.3 Inclusion and Exclusion Criteria
1.4 Key Findings
1.5 Assumptions and Limitations
1.6 Global Market Scenario
1.7 Industry Outlook
1.8 Key Trends
1.9 Patent Analysis
1.9.1 Awaited Technological Developments
1.9.2 Patent Filing Trend (by Country/Cluster)
1.9.3 Patent Filing Trend (by Year)
1.10 Product Benchmarking
1.11 Impact of COVID-19 on Global Antibody Hit Generation and Screening Market
1.12 Impact on Market Size
1.13 Market Entry Barriers and Opportunities
1.14 Business Dynamics
1.15 Impact Analysis

2. Global Antibody Hit Generation and Screening Market (by Technologies)
2.1 Opportunity Assessment
2.2 Growth Share Matrix
2.2.1 Hit Generation
2.2.2 Phage display
2.2.3 Yeast display
2.2.4 Ribosome display
2.2.5 B-cell hybridoma technology
2.2.6 Computational tools
2.2.7 Screening

3. Global Antibody Hit Generation and Screening Market (by Antibody Type)
3.1 Opportunity Assessment
3.2 Growth Share Matrix
3.2.1 Humanized Antibody
3.2.2 Human Antibody
3.2.3 Chimeric Antibody
3.2.4 Murine Antibody

4. Global Antibody Hit Generation and Screening Market (by Applications)
4.1 Opportunity Assessment
4.2 Growth Share Matrix
4.2.1 Cancer
4.2.2 Autoimmune diseases
4.2.3 Infectious diseases

5. Region
5.1 North America Antibody Hit Generation and Screening Market
5.2 Key Findings and Opportunity Assessment
5.3 Regulatory Framework
5.4 Market Dynamics
5.5 Sizing and Forecast Analysis
5.6 Europe Antibody Hit Generation and Screening Market
5.7 Key Findings and Opportunity Assessment
5.8 Regulatory Framework
5.9 Market Dynamics
5.10 Sizing and Forecast Analysis
5.11 Asia-Pacific Antibody Hit Generation and Screening Market
5.12 Key Findings and Opportunity Assessment
5.13 Regulatory Framework
5.14 Market Dynamics
5.15 Sizing and Forecast Analysis
5.16 Latin America Antibody Hit Generation and Screening Market
5.17 Key Findings and Opportunity Assessment
5.18 Regulatory Framework
5.19 Market Dynamics
5.20 Sizing and Forecast Analysis
5.21 Rest-of-the-World Antibody Hit Generation and Screening Market
5.22 Key Findings and Opportunity Assessment
5.23 Regulatory Framework
5.24 Market Dynamics
5.25 Sizing and Forecast Analysis

6. Markets
6.1 Competitive Benchmarking and Company Profiles
6.2 Competitive Landscape
6.3 Company Profiles

F. Hoffmann-La Roche
AbbVie
Pfizer
AstraZeneca
Novartis
Eli Lilly
WuXi AppTec
Charles River Laboratories
Syngenta
BioLegend
Creative Biolabs
Eurofins CDMO
AbCellera
MorphoSys
Evelo Biosciences
Icos Therapeutics
Argenx
Kymab
Alnylam Pharmaceuticals
SAb Biotherapeutics

For more information about this report visit https://www.researchandmarkets.com/r/6lpj4n

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets